National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatmentsOriginal Article Published on 2021-01-072023-06-15 Journal: Journal of the American Academy of Dermatology [Category] MERS, [키워드] biologics CI, Confidence interval COVID-19 EUA, Emergency Use Authorization FDA, US Food and Drug Administration IL, interleukin mRNA, messenger RNA NPF, National Psoriasis Foundation OR, odds ratio PsA, psoriatic arthritis psoriasis psoriatic arthritis RR, relative risk SARS-CoV-2 SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 TF, Task Force TNFi, tumor necrosis factor inhibitors Vaccines [DOI] 10.1016/j.jaad.2020.12.058 PMC 바로가기 [Article Type] Original Article
COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherenceResearch article Published on 2021-01-012022-10-05 Journal: Joint bone spine [Category] SARS, 치료법, [키워드] age anti-rheumatic drug clinical Complete Contagion COVID-19 COVID-19 pandemic COVID19 death Descriptive statistics disease Disease activity dosage drug Evidence Factor Features female FIVE France French Hospitalized identify incidence increased risk Infection Inflammatory lockdown Logistic regression medication Non-steroidal anti-inflammatory drugs objective observé Patient patients platform Predictive psoriatic arthritis questionnaire Registered Result rheumatic disease rheumatoid arthritis rheumatology risk factor SARS-CoV-2 SARS-COV-2 infection secure severity of COVID-19 spondyloarthritis Symptoms the patient Treatment were assessed were used with COVID-19 [DOI] 10.1016/j.jbspin.2020.105095 [Article Type] Research article
Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trialsClinical Science Published on 2020-12-252024-09-04 Journal: Rheumatology (Oxford, England) [Category] 대상포진, [키워드] axial spondyloarthritis IL-17 Ixekizumab psoriasis psoriatic arthritis Safety [DOI] 10.1093/rheumatology/keaa189 PMC 바로가기 [Article Type] Clinical Science
Anti-IL-17A treatment reduces serum inflammatory, angiogenic and tissue remodeling biomarkers accompanied by less synovial high endothelial venules in peripheral spondyloarthritisArticle Published on 2020-12-032023-08-29 Journal: Scientific Reports [Category] E형 간염, [키워드] ankylosing spondylitis chronic inflammation Cytokines immunology Inflammation psoriatic arthritis Rheumatic diseases rheumatology spondyloarthritis [DOI] 10.1038/s41598-020-78204-6 PMC 바로가기 [Article Type] Article
Tweets by People With Arthritis During the COVID-19 Pandemic: Content and Sentiment AnalysisOriginal Paper Published on 2020-12-032022-10-30 Journal: Journal of Medical Internet Research [Category] COVID-19, MERS, SARS, [키워드] Analysis analyzed Anxiety Arthritis assist Care clinician Combination conditions connection content content analysis COVID-19 COVID-19 pandemic demonstrated early phase emotional English Evidence female Health highlight identify include individual information majority management medication microblogging negative emotion Novel coronavirus objective Pain pandemic physical positive presenting professional psoriatic arthritis Psychological distress psychological symptom receive reported Research Result rheumatoid arthritis SARS-CoV-2 sentiment analysis social media symptom burden Symptoms systemic lupus erythematosus The United States therapy Treatment Tweeter Twitter understanding unique was used [DOI] 10.2196/24550 PMC 바로가기 [Article Type] Original Paper
COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain북스페인에서 생물학적 면역억제제 대 아프레밀라스트에 대한 건선 및 건선성 관절염을 가진 COVID-19 환자Comparative Study Published on 2020-11-012022-09-12 Journal: Dermatologic therapy [Category] 진단, [키워드] acute respiratory distress acute respiratory syndrome anti-inflammatory cytokines apremilast autoimmune condition biologic clinical Clinical data clinically Comorbidity coronavirus coronavirus disease COVID-19 COVID-19 patient Critical Cytokines Dermatology higher risk Hyperinflammatory illnesses immunomodulatory infected with COVID-19 Infection Inflammatory infliximab Lung injury management North outcome Patient patients psoriasis psoriatic arthritis rheumatology safety profile SARS-CoV-2 Seven severity shown Spain Symptoms the cytokine storm therapy Treatment [DOI] 10.1111/dth.13961 PMC 바로가기 [Article Type] Comparative Study
Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1)Clinical Science Published on 2020-10-072024-09-04 Journal: Rheumatology (Oxford, England) [Category] 대상포진, [키워드] DMARDs (biologic) Ixekizumab psoriasis psoriatic arthritis spondyloarthritis [DOI] 10.1093/rheumatology/kez684 PMC 바로가기 [Article Type] Clinical Science
Association between autoimmune diseases and COVID-19 as assessed in both a test-negative case–control and population case–control designOriginal Research Published on 2020-10-062022-10-27 Journal: Autoimmunity Highlights [Category] COVID-19, [키워드] Analysis association Autoimmune Autoimmune disease Autoimmune diseases Characteristics Cohort correlated COVID-19 COVID-19 case COVID-19 epidemic defined disease Evidence Hashimoto’s disease hemolytic anemia higher risk increased risk infodemic information initial knowledge outbreak performed positive protection psoriatic arthritis recommendation replicate respiratory infection Result rheumatoid arthritis risk factor SARS-CoV-2 SARS-COV-2 infection spondylitis Spread statistically significant subject subjects Symptoms systemic lupus erythematosus Systemic sclerosis test-negative design tested web-based platform worse prognosis [DOI] 10.1186/s13317-020-00141-1 PMC 바로가기 [Article Type] Original Research
Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?표적 면역억제제로 치료받은 류마티스 질환 환자의 코로나19 발병률: 관찰 데이터에서 무엇을 배울 수 있습니까?Article Published on 2020-10-012022-09-11 Journal: Arthritis & rheumatology (Hoboken, N.J.) [Category] 치료제, [키워드] age Arthritis Attitude Behavior biologic Can changes in close contact confirmed COVID-19 case Connective tissue diseases contact with coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 case COVID-19 cases COVID-19 infection detect disease Disease activity Diseases drug General population identify incidence incidence of COVID-19 Infection intensive care treatment Italian lombardy long-term treatment management Nasopharyngeal swab not significantly different Patient patients patients treated positive Precaution precautions Prevent psoriatic arthritis reflected regimens remained required rheumatic disease Rheumatic diseases rheumatoid arthritis rheumatology severe complication severe complications severity severity of COVID-19 spondyloarthritis Statistics Symptom synthetic drug synthetic drugs tested the patient therapy treated Treatment was obtained women [DOI] 10.1002/art.41388 PMC 바로가기 [Article Type] Article
The Risk of Systemic Diseases in Those with Psoriasis and Psoriatic Arthritis: From Mechanisms to ClinicReview Published on 2020-09-242024-09-02 Journal: International Journal of Molecular Sciences [Category] 대상포진, [키워드] Autoimmune disease Cancer cardiovascular disease Comorbidity Infection metabolic syndrome psoriasis psoriatic arthritis sleep disorder [DOI] 10.3390/ijms21197041 PMC 바로가기 [Article Type] Review